Tarver Promises Scientific And Creative Approach To Top CDRH Role

Michelle Tarver, acting director of the US FDA’s device center, discussed her background and how she plans to lead CDRH during a recent webinar organized by the Pathway for Patient Health. Key to her philosophy are a strong academic background and a creative drive, she says.

Michelle Tarver, Jeff Shuren, and Pathway for Patient Health President Marla Phillips are seen during a 24 September webinar.
Acting CDRH director Michelle Tarver and former device center head Jeff Shuren spoke during a webinar facilitated by Pathway for Patient Health president Marla Phillips. • Source: Citeline

More from Regulation

More from Policy & Regulation